S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Average US gasoline price falls 45 cents to $4.10 per gallon
Here’s How the Inflation Reduction Act Energizes Power Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Average US gasoline price falls 45 cents to $4.10 per gallon
Here’s How the Inflation Reduction Act Energizes Power Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Average US gasoline price falls 45 cents to $4.10 per gallon
Here’s How the Inflation Reduction Act Energizes Power Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Average US gasoline price falls 45 cents to $4.10 per gallon
Here’s How the Inflation Reduction Act Energizes Power Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)

Livongo Health Will Be a Buy As It Merges With Teladoc

Livongo Health Will Be a Buy As It Merges With Teladoc

Shares of Livongo Health (NASDAQ:LVGO) are up 6% in early trading as investors are celebrating the company’s stellar earnings report. Livongo shattered earnings expectations by posting earnings of 11 cents per share. Analysts were forecasting negative earnings of 6 cents per share. Revenue came in equally strong as the company posted $91.9 million, easily outpacing expectations for $86.8 million.  

But the strong report was still overshadowed as investors continue to digest the announcement of its merger with Teladoc Health (NYSE:TDOC). Shares had initially tumbled on August 5 as some analysts felt that the $18.5 billion price tag that Teladoc is paying may be too much for a stock that is already up 434% in 2020.

However, conventional wisdom is turning bullish. And with good reason. According to Grand View Research, the global digital health market grew from $95.8 billion in 2018 to $114.5 billion in 2019. And this year that number is expected to reach $144.4 billion.

The Covid-19 pandemic is a catalyst for telehealth

The need and or desire to stay at home has expanded the use of e-commerce. And this has rewarded the companies that had a strong e-commerce presence before the pandemic.

The same dynamic is working out in telehealth. Some patients were reluctant to use telehealth for a variety of reasons. However, with many doctors offices closed, telehealth services have become not only a viable option but, in some cases, the only option.


In an interview with CNBC, Brian Cuneo, global co-chair of the life sciences and health care group at the law firm Latham & Watkins made these remarks, “What we’ve seen with COVID is its been the catalyst in many ways for people to rethink lots of different areas of life, and access to and delivery of health care is one of the first and foremost.”

By itself, Livongo isn’t a perfect fit for the doctor-patient virtual visit model. The company comes at telehealth a little differently from Teladoc. Livongo sells personalized coaching services to employers and health systems. Those customers then offer Livongo’s services to their employees and/or members. At the end of March, Livongo had expanded its client base to 1,328 clients – a 6% sequential increase.

The company’s popular product, which was also its proof of concept, is diabetes management. And it currently has 410,000 members, a 113% year-over-year increase. Livongo is expanding into other areas including hypertension/high blood pressure, weight management, and mental/behavioral health.

A perfect fit

It’s rare when a merger is considered a perfect fit, but that’s the early commentary on Livongo’s merger with Teladoc Health. Analysts look at it, I believe correctly, as the merger of a lock and a key.

Teladoc Health and Livongo Health announced an agreement to merge. The deal is valued at $18.5 billion and will create a company that will leverage the strengths of both companies in providing virtual care.

“Livongo is a world-class innovator we deeply admire and has demonstrated success in improving the lives of people living with chronic conditions,” Teladoc Chief Executive Jason Gorevic said in a statement. “Together, we will further transform the health care experience from preventive care to the most complex cases, bringing ‘whole person’ health to consumers and greater value to our clients and shareholders as a result.”

Analysts see the merger as a major step forward in advancing digital health care at a time when the novel coronavirus is expanding the adoption of digital and remote health care services.

David Larsen of Verity Research describes what the synergy between the two companies may look like. “When a Livongo member communicates with a health coach, we suspect that many times this health coach would in theory like to be able to refer the member to a physician, and they would like to be able to provide more in-depth care and services for other ailments that members may have.”

“By combining with Teladoc, Livongo members will have access to expert physician communications, their own primary care physician, they will have the ability to get prescriptions written for them, and this combined platform truly gives the entire world a digital health care solution,” Larsen wrote in a note to clients.

Analysts project he combined company will have $1.3 billion in revenue for 2020. The deal is expected to close in the fourth quarter.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Livongo Health (LVGO)
0 of 5 stars
$139.77flatN/A-349.42N/AN/A
Teladoc Health (TDOC)
2.5676 of 5 stars
$40.32+6.1%N/A-0.66Hold$67.20
Compare These Stocks  Add These Stocks to My Watchlist 

7 Dividend Aristocrats to Help You Take the Bite Out of the Bear

Investing in a bull market is fun and relatively easy. When the major indexes are hitting new highs seemingly every day, it's easy to find stocks to buy. By contrast, investing in a bear market may not be as enjoyable. But it's necessary, and when you have a strategy it doesn't have to be hard.

One timeless bear market strategy is to buy dividend stocks. And for investors looking to take even more risk out of this strategy, investors can elect to buy a group of stocks known as dividend aristocrats. These are companies that have a history of issuing, and growing, its dividend year – after year – after year. In fact, to be a member of this exclusive group, a company must have increased its dividend every year for at least 25 consecutive years.

In this special presentation, we'll analyze seven dividend aristocrats who are giving investors a good balance between growth and value. This makes them strong additions to your portfolio as part of a defensive strategy to weather a recession.

Here are 7 dividend aristocrats that can help your portfolio thrive in a bear market.

View the "7 Dividend Aristocrats to Help You Take the Bite Out of the Bear".

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastInvesting in What You Know Has Changed

What investors can learn from studying the past, as well as offering some ideas about asset classes with future potential.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.